AVR 3.19% $15.15 anteris technologies ltd

Upcoming Immunotherapies Deal (???), page-6

  1. 734 Posts.
    lightbulb Created with Sketch. 130
    Wayne gave many hints in last AGM to support Eire view point:

    - No more funding from us,

    if we remain a major holder, then we will be forced to contribute.

    Wayne also alluded on many occasions that the Vax was a too big of a project for Admedus to handle, so I also have the view point that someone will be buying a big chunk out from VAX, that someone will have a controlling share, anywhere above the 51%, AHZ gets paid back whatever they invested in, while retaining a 10% to 15% Share free carried.

    If the Vaccine becomes a reality say in 5 years from now, we will still receive a cut out of the profits.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.